Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1980 2
1985 1
1992 1
1995 2
1996 2
1997 5
1998 4
1999 1
2000 1
2001 1
2002 3
2003 4
2004 4
2005 3
2006 2
2007 4
2009 3
2011 2
2012 1
2013 3
2014 2
2015 1
2016 3
2018 2
2019 2
2020 1
2021 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Anti-IgE treatment in allergic rhinitis.
Bayar Muluk N, Bafaqeeh SA, Cingi C. Bayar Muluk N, et al. Int J Pediatr Otorhinolaryngol. 2019 Dec;127:109674. doi: 10.1016/j.ijporl.2019.109674. Epub 2019 Sep 10. Int J Pediatr Otorhinolaryngol. 2019. PMID: 31526939 Review.
OBJECTIVES: To review the efficacy of anti-IgE therapy in allergic rhinitis (AR). METHODS: Literature search was performed using the PubMed and Proquest Central databases at Kirikkale University Library. ...CONCLUSION: Omalizumab has efficacy in ameliorating …
OBJECTIVES: To review the efficacy of anti-IgE therapy in allergic rhinitis (AR). METHODS: Literature search was perfor …
Emerging drugs for the treatment of perennial allergic rhinitis.
Licari A, Castagnoli R, Bottino C, Marseglia A, Marseglia G, Ciprandi G. Licari A, et al. Expert Opin Emerg Drugs. 2016;21(1):57-67. doi: 10.1517/14728214.2016.1139082. Epub 2016 Jan 25. Expert Opin Emerg Drugs. 2016. PMID: 26733401 Review.
Perennial allergic rhinitis is caused by allergens present around the year. AREAS COVERED: Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines currently recommend a stepwise therapeutic approach that combines patient education wi …
Perennial allergic rhinitis is caused by allergens present around the year. AREAS COVERED: Allergic Rhinitis …
Rhinophototherapy, an alternative treatment of allergic rhinitis: Systematic review and meta-analysis.
Costa TMR, Carneiro FM, Oliveira KAS, Souza MFB, Avelino MAG, Wastowski IJ. Costa TMR, et al. Braz J Otorhinolaryngol. 2021 Nov-Dec;87(6):742-752. doi: 10.1016/j.bjorl.2020.12.016. Epub 2021 Feb 16. Braz J Otorhinolaryngol. 2021. PMID: 33663975 Free PMC article. Review.
INTRODUCTION: Allergic rhinitis is a chronic inflammatory disease of the nasal mucosa, mediated by immunoglobulin E, affecting 1 in 6 individuals. ...OBJECTIVE: To identify the effectiveness of phototherapy in the treatment of allergic rhinitis through …
INTRODUCTION: Allergic rhinitis is a chronic inflammatory disease of the nasal mucosa, mediated by immunoglobulin E, affecting …
Intranasal antihistamines and corticosteroids in the treatment of allergic rhinitis: a systematic review and meta-analysis protocol.
Sousa-Pinto B, Vieira RJ, Brozek J, Cardoso-Fernandes A, Lourenço-Silva N, Ferreira-da-Silva R, Ferreira A, Gil-Mata S, Bedbrook A, Klimek L, Fonseca JA, Zuberbier T, Schünemann HJ, Bousquet J. Sousa-Pinto B, et al. BMJ Open. 2023 Nov 2;13(11):e076614. doi: 10.1136/bmjopen-2023-076614. BMJ Open. 2023. PMID: 37918935 Free PMC article.
INTRODUCTION: Intranasal antihistamines and corticosteroids are some of the most frequently used drug classes in the treatment of allergic rhinitis. However, there is uncertainty as to whether effectiveness differences may exist among different intranasal specific m …
INTRODUCTION: Intranasal antihistamines and corticosteroids are some of the most frequently used drug classes in the treatment of allergi …
Barrier-enforcing measures as treatment principle in allergic rhinitis: a systematic review.
Andersson M, Greiff L, Ojeda P, Wollmer P. Andersson M, et al. Curr Med Res Opin. 2014 Jun;30(6):1131-7. doi: 10.1185/03007995.2014.882299. Epub 2014 Jan 30. Curr Med Res Opin. 2014. PMID: 24405331 Review.
BACKGROUND AND OBJECTIVES: Barrier-enforcing measures have been suggested as treatment options for allergic rhinitis. This review identifies and describes the literature on the subject. METHODS: Relevant publications were searched for in the PubMed database (search …
BACKGROUND AND OBJECTIVES: Barrier-enforcing measures have been suggested as treatment options for allergic rhinitis. This rev …
Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
Klimek L, Mullol J, Hellings P, Gevaert P, Mösges R, Fokkens W. Klimek L, et al. Expert Opin Pharmacother. 2016;17(5):657-69. doi: 10.1517/14656566.2016.1145661. Epub 2016 Mar 3. Expert Opin Pharmacother. 2016. PMID: 26800187 Review.
INTRODUCTION: Allergic rhinitis (AR) has a major negative impact on patients' quality of life (QoL) and carries a high socio economic burden. This is particularly the case for patients who experience symptoms for extended periods of time (i.e. those with perennia …
INTRODUCTION: Allergic rhinitis (AR) has a major negative impact on patients' quality of life (QoL) and carries a high socio e …
Treatment of allergic rhinitis.
Rosenwasser LJ. Rosenwasser LJ. Am J Med. 2002 Dec 16;113 Suppl 9A:17S-24S. doi: 10.1016/s0002-9343(02)01433-x. Am J Med. 2002. PMID: 12517578 Review.
Allergic rhinitis, a common and often debilitating disease marked by rhinorrhea, nasal congestion, nasal itching, and sneezing, is on the increase worldwide. ...This overview describes the characteristics, pathogenesis, and diagnosis of allergic rhinitis …
Allergic rhinitis, a common and often debilitating disease marked by rhinorrhea, nasal congestion, nasal itching, and sneezing …
MP29-02: a breakthrough for the treatment of allergic rhinitis.
Bernstein JA. Bernstein JA. Expert Opin Pharmacother. 2013 Oct;14(15):2101-13. doi: 10.1517/14656566.2013.828693. Epub 2013 Aug 26. Expert Opin Pharmacother. 2013. PMID: 23977840 Review.
INTRODUCTION: Allergic rhinitis (AR) can be challenging to treat. For many patients, current therapies (including multiple therapies) provide insufficient symptom relief. ...EXPERT OPINION: MP29-02 represents a breakthrough in AR management for the fol …
INTRODUCTION: Allergic rhinitis (AR) can be challenging to treat. For many patients, current therapies (including multi …
Bepotastine besilate for the treatment of perennial allergic rhinitis.
Carrillo-Martin I, Gonzalez-Estrada A, Dimov V. Carrillo-Martin I, et al. Expert Opin Pharmacother. 2018 Oct;19(15):1727-1730. doi: 10.1080/14656566.2018.1519020. Epub 2018 Sep 12. Expert Opin Pharmacother. 2018. PMID: 30208284
Bepotastine besilate (BB) is a second-generation H1-antihistamine that, as an ophthalmic solution, is approved in the United States by the Food and Drug Administration (FDA) for the treatment of allergic conjunctivitis. In other countries, the oral presentation of BB is wi …
Bepotastine besilate (BB) is a second-generation H1-antihistamine that, as an ophthalmic solution, is approved in the United States by the F …
Etiopathogenesis and management of perennial allergic rhinitis: a state-of-the-art review.
Bush RK. Bush RK. Treat Respir Med. 2004;3(1):45-57. doi: 10.2165/00151829-200403010-00006. Treat Respir Med. 2004. PMID: 15174893 Review.
Perennial allergic rhinitis is an inflammatory disorder characterized by symptoms of nasal congestion, rhinorrhea, sneezing, and itching. ...Omalizumab is the first of several new immune-based specifically targeted molecules that may prove to be extremely val …
Perennial allergic rhinitis is an inflammatory disorder characterized by symptoms of nasal congestion, rhinorrhea, snee …
63 results